Mirae Asset Global Etfs Holdings Ltd. Harrow Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 18,146 shares of HROW stock, worth $480,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,146
Previous 17,356
4.55%
Holding current value
$480,506
Previous $582,000
17.18%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$105 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$56.9 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$50.1 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$49.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$25.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $717M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...